Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Weitzman

Showing results (171-180 of 181) with videos related to

Pageof 19
Sort By:
Pediatric Blood & Cancer|September 25, 2004
Health status of young children during therapy for advanced neuroblastomaP C Nathan, W Furlong, S De Pauw, et al.
Stroke|January 1, 1994
Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Atherosclerosis Risk in Communities (ARIC) Study InvestigatorsA R Folsom, J H Eckfeldt, S Weitzman, et al.
Neurosurgery|May 1, 1993
Primary leptomeningeal melanoma: an unusually aggressive tumor in childhoodD Allcutt, S Michowiz, S Weitzman, et al.
Paediatrics & Child Health|January 20, 2010
Practical vaccination guidelines for children with cancerL Sung, H Heurter, K M Zokvic, et al.
Bone Marrow Transplantation|October 21, 2003
Allogeneic bone marrow transplantation vs chemotherapy for children with Philadelphia chromosome-positive acute lymphoblastic leukemiaA Sharathkumar, E F Saunders, Y Dror, et al.
Leukemia & Lymphoma|November 9, 2001
Results of a randomized phase III trial in children and adolescents with advanced stage diffuse large cell non Hodgkin's lymphoma: a Pediatric Oncology Group studyJ H Laver, H Mahmoud, T E Pick, et al.
The Journal of Biological Chemistry|June 8, 1999
p300/cAMP-responsive element-binding protein interactions with ets-1 and ets-2 in the transcriptional activation of the human stromelysin promoterG Jayaraman, R Srinivas, C Duggan, et al.
The Journal of Laboratory and Clinical Medicine|March 1, 1989
Characterization of a novel myeloma cell line, MM.1R E Goldman-Leikin, H R Salwen, C V Herst, et al.
Lancet (London, England)|December 21, 1996
A population-based study of the usefulness of screening for neuroblastomaW G Woods, M Tuchman, L L Robison, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Screening for neuroblastoma is ineffective in reducing the incidence of unfavourable advanced stage disease in older childrenW G Woods, M Tuchman, L L Robison, et al.
Pageof 19

Showing results (171-180 of 181) with videos related to

Sort By:
Pageof 19
Pediatric Blood & Cancer|September 25, 2004
Health status of young children during therapy for advanced neuroblastomaP C Nathan, W Furlong, S De Pauw, et al.
Stroke|January 1, 1994
Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Atherosclerosis Risk in Communities (ARIC) Study InvestigatorsA R Folsom, J H Eckfeldt, S Weitzman, et al.
Neurosurgery|May 1, 1993
Primary leptomeningeal melanoma: an unusually aggressive tumor in childhoodD Allcutt, S Michowiz, S Weitzman, et al.
Paediatrics & Child Health|January 20, 2010
Practical vaccination guidelines for children with cancerL Sung, H Heurter, K M Zokvic, et al.
Bone Marrow Transplantation|October 21, 2003
Allogeneic bone marrow transplantation vs chemotherapy for children with Philadelphia chromosome-positive acute lymphoblastic leukemiaA Sharathkumar, E F Saunders, Y Dror, et al.
Leukemia & Lymphoma|November 9, 2001
Results of a randomized phase III trial in children and adolescents with advanced stage diffuse large cell non Hodgkin's lymphoma: a Pediatric Oncology Group studyJ H Laver, H Mahmoud, T E Pick, et al.
The Journal of Biological Chemistry|June 8, 1999
p300/cAMP-responsive element-binding protein interactions with ets-1 and ets-2 in the transcriptional activation of the human stromelysin promoterG Jayaraman, R Srinivas, C Duggan, et al.
The Journal of Laboratory and Clinical Medicine|March 1, 1989
Characterization of a novel myeloma cell line, MM.1R E Goldman-Leikin, H R Salwen, C V Herst, et al.
Lancet (London, England)|December 21, 1996
A population-based study of the usefulness of screening for neuroblastomaW G Woods, M Tuchman, L L Robison, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Screening for neuroblastoma is ineffective in reducing the incidence of unfavourable advanced stage disease in older childrenW G Woods, M Tuchman, L L Robison, et al.
Pageof 19